Delivery Order SPE2DB22D2005-SPE2DB24FJJG1
- Not listed
- This federal contract award, valued at $2,411.52, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication LINZESS 290 MCG CAPSULE UU 30S, with a period of performance through November 30, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a separate $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,509.95, is a delivery order for the medication LINZESS 290 MCG CAPSULE UU 30S. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under the Amerisourcebergen brand. Cencora, Inc. holds a significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LINZESS 290 MCG CAPSULE in the amount of $3,680.45. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Linzess 290 MCG capsules. The $7,821.77 contract is a firm fixed-price delivery order with a completion date of March 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $4,039.95, is a Firm Fixed Price Delivery Order to supply LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The award is not designated as a set-aside and was made through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,707.34 firm-fixed-price delivery order is for the pharmaceutical product LINZESS 145 MCG CAPSULE. The contract has an ultimate completion date of October 21, 2021. This appears to be part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $2,653.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product LINZESS 290 MCG CAPSULE UU 30S, with a period of performance through December 6, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $1,004.70, is a Firm Fixed Price Delivery Order contract for the pharmaceutical product LINZESS 145MCG 30S. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, that serves as the primary vehicle for the company to...
- This federal contract award, valued at $1,238.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Linzess 72 MCG capsules, a specialty medication. The award was made under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., worth up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,647.76, is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJJG1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $1,184.61, is a Firm Fixed Price Delivery Order for the supply of the prescription medication LINZESS 72 MCG CAPSULE. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This contract award is likely a specific delivery order placed against that larger IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/27/24 |